AJP - Lung Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 287: L577-L583, 2004. First published May 21, 2004; doi:10.1152/ajplung.00449.2003
1040-0605/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/3/L577    most recent
00449.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pauvert, O.
Right arrow Articles by Savineau, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pauvert, O.
Right arrow Articles by Savineau, J.-P.

Sildenafil alters calcium signaling and vascular tone in pulmonary arteries from chronically hypoxic rats

Olivier Pauvert,1 Sébastien Bonnet,1 Eric Rousseau,2 Roger Marthan,1 and Jean-Pierre Savineau1

1Laboratoire de Physiologie Cellulaire Respiratoire, Institut National de la Santé et de la Recherche Médicale (E 356 and Institut Fédératif de Recherche 4), Université Bordeaux 2, 33076 Bordeaux, France; and 2Le Bilarium, Département de Physiologie et Biophysique, Université de Sherbrooke, Sherbrooke, Quebec J1H 5N4, Canada

Submitted 22 December 2003 ; accepted in final form 18 May 2004

Sildenafil, a potent type 5 nucleotide-dependent phosphodiesterase (PDE) inhibitor, has been recently proposed as a therapeutic tool to treat or prevent pulmonary artery hypertension (PAHT). We thus studied the effect of sildenafil on both the calcium signaling of isolated pulmonary artery smooth muscle cells (PASMCs) and the reactivity of pulmonary artery (PA) obtained from chronic hypoxia (CH)-induced pulmonary hypertensive rats compared with control (normoxic) rats. CH rats were maintained in an hypobaric chamber (50.5 kPa) for 3 wk leading to full development of PAHT. Intracellular calcium concentration ([Ca2+]i) was measured in PASMCs loaded with the calcium fluorophore indo 1. Unlike in control rats, sildenafil (10–100 nM) decreased the resting [Ca2+]i value in PASMCs obtained from CH rats. In PASMCs from both control and CH rats, sildenafil concentration dependently inhibited the [Ca2+]i response induced by G-coupled membrane receptor agonists such as angiotensin II and phenylephrine but had no effect on the amplitude of the [Ca2+]i response induced by caffeine. Sildenafil (0.1 nM–1 µM) concentration dependently reduced basal PA tone that is present in CH rats and relaxed PA rings precontracted with phenylephrine in both control and CH rats. These data show that sildenafil is a potent pulmonary artery relaxant in CH rats and that it normalizes CH-induced increases in resting [Ca2+]i and basal tone. Consequently, pharmacological inhibition of sildenafil-sensitive PDE5 downregulates the Ca2+ signaling pathway involved in this model of pulmonary hypertension.

pulmonary hypertension; vascular smooth muscle; phosphodiesterase 5; pulmonary vasodilator



Address for reprint requests and other correspondence: J.-P. Savineau, Laboratoire de Physiologie Cellulaire Respiratoire, INSERM (E 356 and IFR 4), Université Bordeaux 2, 146 rue Léo Saignat, 33076 Bordeaux, France (E-mail: jean-pierre.savineau{at}u-bordeaux2.fr)




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Morin, C. Guibert, M. Sirois, V. Echave, M. M. Gomes, and E. Rousseau
Effects of {omega}-hydroxylase product on distal human pulmonary arteries
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1435 - H1443.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
R. Robert, J-P. Savineau, C. Norez, F. Becq, and C. Guibert
Expression and function of cystic fibrosis transmembrane conductance regulator in rat intrapulmonary arteries
Eur. Respir. J., November 1, 2007; 30(5): 857 - 864.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
F. Murray, H. H. Patel, R. Y. S. Suda, S. Zhang, P. A. Thistlethwaite, J. X.-J. Yuan, and P. A. Insel
Expression and activity of cAMP phosphodiesterase isoforms in pulmonary artery smooth muscle cells from patients with pulmonary hypertension: role for PDE1
Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L294 - L303.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.